-
1
-
-
84902489371
-
The epidemiology of glioma in adults: a "state of the science" review
-
Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS. The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol. 2014; 16:896-913.
-
(2014)
Neuro Oncol
, vol.16
, pp. 896-913
-
-
Ostrom, Q.T.1
Bauchet, L.2
Davis, F.G.3
Deltour, I.4
Fisher, J.L.5
Langer, C.E.6
Pekmezci, M.7
Schwartzbaum, J.A.8
Turner, M.C.9
Walsh, K.M.10
Wrensch, M.R.11
Barnholtz-Sloan, J.S.12
-
2
-
-
68049117331
-
Glioblastoma multiforme: a review of where we have been and where we are going
-
Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, Bigner DD. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs. 2009; 18:1061-1083.
-
(2009)
Expert Opin Investig Drugs
, vol.18
, pp. 1061-1083
-
-
Adamson, C.1
Kanu, O.O.2
Mehta, A.I.3
Di, C.4
Lin, N.5
Mattox, A.K.6
Bigner, D.D.7
-
3
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352:987-996.
-
(2005)
N Engl J Med
, vol.352
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
van den Bent, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.6
Belanger, K.7
Brandes, A.A.8
Marosi, C.9
Bogdahn, U.10
Curschmann, J.11
Janzer, R.C.12
Ludwin, S.K.13
-
4
-
-
84856209607
-
Frizzled7 as an emerging target for cancer therapy
-
King TD, Zhang W, Suto MJ, Li Y. Frizzled7 as an emerging target for cancer therapy. Cell Signal. 2012; 24:846-851.
-
(2012)
Cell Signal
, vol.24
, pp. 846-851
-
-
King, T.D.1
Zhang, W.2
Suto, M.J.3
Li, Y.4
-
5
-
-
79953656755
-
Genotypic and phenotypic characterization of side population of gastric cancer cell lines
-
Schmuck R, Warneke V, Behrens HM, Simon E, Weichert W, Rocken C. Genotypic and phenotypic characterization of side population of gastric cancer cell lines. Am J Pathol. 2011; 178:1792-1804.
-
(2011)
Am J Pathol
, vol.178
, pp. 1792-1804
-
-
Schmuck, R.1
Warneke, V.2
Behrens, H.M.3
Simon, E.4
Weichert, W.5
Rocken, C.6
-
6
-
-
70349975727
-
Downregulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells
-
Ueno K, Hazama S, Mitomori S, Nishioka M, Suehiro Y, Hirata H, Oka M, Imai K, Dahiya R, Hinoda Y. Downregulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer. 2009; 101:1374-1381.
-
(2009)
Br J Cancer
, vol.101
, pp. 1374-1381
-
-
Ueno, K.1
Hazama, S.2
Mitomori, S.3
Nishioka, M.4
Suehiro, Y.5
Hirata, H.6
Oka, M.7
Imai, K.8
Dahiya, R.9
Hinoda, Y.10
-
7
-
-
84863938543
-
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
-
Gurney A, Axelrod F, Bond CJ, Cain J, Chartier C, Donigan L, Fischer M, Chaudhari A, Ji M, Kapoun AM, Lam A, Lazetic S, Ma S, et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci U S A. 2012; 109:11717-11722.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 11717-11722
-
-
Gurney, A.1
Axelrod, F.2
Bond, C.J.3
Cain, J.4
Chartier, C.5
Donigan, L.6
Fischer, M.7
Chaudhari, A.8
Ji, M.9
Kapoun, A.M.10
Lam, A.11
Lazetic, S.12
Ma, S.13
-
8
-
-
84879724501
-
MGMT promoter methylation and glioblastoma prognosis: a systematic review and meta-analysis
-
Chen Y, Hu F, Zhou Y, Chen W, Shao H, Zhang Y. MGMT promoter methylation and glioblastoma prognosis: a systematic review and meta-analysis. Arch Med Res. 2013; 44:281-290.
-
(2013)
Arch Med Res
, vol.44
, pp. 281-290
-
-
Chen, Y.1
Hu, F.2
Zhou, Y.3
Chen, W.4
Shao, H.5
Zhang, Y.6
-
9
-
-
84891482900
-
IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis
-
Cheng HB, Yue W, Xie C, Zhang RY, Hu SS, Wang Z. IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis. Tumour Biol. 2013; 34:3555-3559.
-
(2013)
Tumour Biol
, vol.34
, pp. 3555-3559
-
-
Cheng, H.B.1
Yue, W.2
Xie, C.3
Zhang, R.Y.4
Hu, S.S.5
Wang, Z.6
-
10
-
-
84865463572
-
Association between prediagnostic IgE levels and risk of glioma
-
Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, Feychting M, Grimsrud TK. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst. 2012; 104:1251-1259.
-
(2012)
J Natl Cancer Inst
, vol.104
, pp. 1251-1259
-
-
Schwartzbaum, J.1
Ding, B.2
Johannesen, T.B.3
Osnes, L.T.4
Karavodin, L.5
Ahlbom, A.6
Feychting, M.7
Grimsrud, T.K.8
-
11
-
-
61649116731
-
Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas
-
Zawlik I, Kita D, Vaccarella S, Mittelbronn M, Franceschi S, Ohgaki H. Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas. Brain Pathol. 2009; 19:188-194.
-
(2009)
Brain Pathol
, vol.19
, pp. 188-194
-
-
Zawlik, I.1
Kita, D.2
Vaccarella, S.3
Mittelbronn, M.4
Franceschi, S.5
Ohgaki, H.6
-
12
-
-
84940439824
-
Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis
-
Zheng CG, Jin C, Ye LC, Chen NZ, Chen ZJ. Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis. Tumour Biol. 2015; 36:5839-5848.
-
(2015)
Tumour Biol
, vol.36
, pp. 5839-5848
-
-
Zheng, C.G.1
Jin, C.2
Ye, L.C.3
Chen, N.Z.4
Chen, Z.J.5
-
13
-
-
20044372154
-
MGMT gene silencing and benefit from temozolomide in glioblastoma
-
Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, MirimanoffRO, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352:997-1003.
-
(2005)
N Engl J Med
, vol.352
, pp. 997-1003
-
-
Hegi, M.E.1
Diserens, A.C.2
Gorlia, T.3
Hamou, M.F.4
de Tribolet, N.5
Weller, M.6
Kros, J.M.7
Hainfellner, J.A.8
Mason, W.9
Mariani, L.10
Bromberg, J.E.11
Hau, P.12
Mirimanoff, R.O.13
-
14
-
-
84907011236
-
Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males
-
Sun T, Warrington NM, Luo J, Brooks MD, Dahiya S, Snyder SC, Sengupta R, Rubin JB. Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males. J Clin Invest. 2014; 124:4123-4133.
-
(2014)
J Clin Invest
, vol.124
, pp. 4123-4133
-
-
Sun, T.1
Warrington, N.M.2
Luo, J.3
Brooks, M.D.4
Dahiya, S.5
Snyder, S.C.6
Sengupta, R.7
Rubin, J.B.8
-
15
-
-
84926429639
-
Glioblastoma: imaging genomic mapping reveals sexspecific oncogenic associations of cell death
-
Colen RR, Wang J, Singh SK, Gutman DA, Zinn PO. Glioblastoma: imaging genomic mapping reveals sexspecific oncogenic associations of cell death. Radiology. 2015; 275:215-227.
-
(2015)
Radiology
, vol.275
, pp. 215-227
-
-
Colen, R.R.1
Wang, J.2
Singh, S.K.3
Gutman, D.A.4
Zinn, P.O.5
-
16
-
-
84969288964
-
Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection
-
Caviglia GP, Abate ML, Petrini E, Gaia S, Rizzetto M, Smedile A. Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection. Hepatol Res. 2015.
-
(2015)
Hepatol Res
-
-
Caviglia, G.P.1
Abate, M.L.2
Petrini, E.3
Gaia, S.4
Rizzetto, M.5
Smedile, A.6
-
17
-
-
84873596512
-
AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma
-
Dumitru CA, Bankfalvi A, Gu X, Zeidler R, Brandau S, Lang S. AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma. PLoS One. 2013; 8:e56420.
-
(2013)
PLoS One
, vol.8
-
-
Dumitru, C.A.1
Bankfalvi, A.2
Gu, X.3
Zeidler, R.4
Brandau, S.5
Lang, S.6
-
18
-
-
84946116693
-
MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas
-
Taguchi A, Rho JH, Yan Q, Zhang Y, Zhao Y, Xu H, Tripathi SC, Wang H, Brenner D, Kucherlapati M, Kucherlapati RS, Boutin A, Wang YA, et al. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas. Cancer Prev Res (Phila). 2015.
-
(2015)
Cancer Prev Res (Phila)
-
-
Taguchi, A.1
Rho, J.H.2
Yan, Q.3
Zhang, Y.4
Zhao, Y.5
Xu, H.6
Tripathi, S.C.7
Wang, H.8
Brenner, D.9
Kucherlapati, M.10
Kucherlapati, R.S.11
Boutin, A.12
Wang, Y.A.13
-
19
-
-
84897389313
-
The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer
-
Weller P, Bankfalvi A, Gu X, Dominas N, Lehnerdt GF, Zeidler R, Lang S, Brandau S, Dumitru CA. The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer. Eur J Cancer. 2014; 50:1291-1300.
-
(2014)
Eur J Cancer
, vol.50
, pp. 1291-1300
-
-
Weller, P.1
Bankfalvi, A.2
Gu, X.3
Dominas, N.4
Lehnerdt, G.F.5
Zeidler, R.6
Lang, S.7
Brandau, S.8
Dumitru, C.A.9
-
20
-
-
77953019788
-
The prognostic IDH1(R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
-
Bleeker FE, Atai NA, Lamba S, Jonker A, Rijkeboer D, Bosch KS, Tigchelaar W, Troost D, Vandertop WP, Bardelli A, Van Noorden CJ. The prognostic IDH1(R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. Acta Neuropathol. 2010; 119:487-494.
-
(2010)
Acta Neuropathol
, vol.119
, pp. 487-494
-
-
Bleeker, F.E.1
Atai, N.A.2
Lamba, S.3
Jonker, A.4
Rijkeboer, D.5
Bosch, K.S.6
Tigchelaar, W.7
Troost, D.8
Vandertop, W.P.9
Bardelli, A.10
Van Noorden, C.J.11
-
21
-
-
69949114447
-
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1, 010 diffuse gliomas
-
Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1, 010 diffuse gliomas. Acta Neuropathol. 2009; 118:469-474.
-
(2009)
Acta Neuropathol
, vol.118
, pp. 469-474
-
-
Hartmann, C.1
Meyer, J.2
Balss, J.3
Capper, D.4
Mueller, W.5
Christians, A.6
Felsberg, J.7
Wolter, M.8
Mawrin, C.9
Wick, W.10
Weller, M.11
Herold-Mende, C.12
Unterberg, A.13
-
22
-
-
80053196609
-
Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications
-
Gupta R, Webb-Myers R, Flanagan S, Buckland ME. Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications. J Clin Pathol. 2011; 64:835-844.
-
(2011)
J Clin Pathol
, vol.64
, pp. 835-844
-
-
Gupta, R.1
Webb-Myers, R.2
Flanagan, S.3
Buckland, M.E.4
-
23
-
-
60849115270
-
IDH1 and IDH2 mutations in gliomas
-
Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009; 360:765-773.
-
(2009)
N Engl J Med
, vol.360
, pp. 765-773
-
-
Yan, H.1
Parsons, D.W.2
Jin, G.3
McLendon, R.4
Rasheed, B.A.5
Yuan, W.6
Kos, I.7
Batinic-Haberle, I.8
Jones, S.9
Riggins, G.J.10
Friedman, H.11
Friedman, A.12
Reardon, D.13
-
24
-
-
80052677148
-
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back?
-
Combs SE, Rieken S, Wick W, Abdollahi A, von Deimling A, Debus J, Hartmann C. Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back? Radiat Oncol. 2011; 6:115.
-
(2011)
Radiat Oncol
, vol.6
, pp. 115
-
-
Combs, S.E.1
Rieken, S.2
Wick, W.3
Abdollahi, A.4
von Deimling, A.5
Debus, J.6
Hartmann, C.7
-
25
-
-
0034626988
-
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
-
Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med. 2000; 343:1350-1354.
-
(2000)
N Engl J Med
, vol.343
, pp. 1350-1354
-
-
Esteller, M.1
Garcia-Foncillas, J.2
Andion, E.3
Goodman, S.N.4
Hidalgo, O.F.5
Vanaclocha, V.6
Baylin, S.B.7
Herman, J.G.8
-
26
-
-
33750580929
-
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study
-
Brandes AA, Tosoni A, Cavallo G, Reni M, Franceschi E, Bonaldi L, Bertorelle R, Gardiman M, Ghimenton C, Iuzzolino P, Pession A, Blatt V, Ermani M, et al. Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. J Clin Oncol. 2006; 24:4746-4753.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4746-4753
-
-
Brandes, A.A.1
Tosoni, A.2
Cavallo, G.3
Reni, M.4
Franceschi, E.5
Bonaldi, L.6
Bertorelle, R.7
Gardiman, M.8
Ghimenton, C.9
Iuzzolino, P.10
Pession, A.11
Blatt, V.12
Ermani, M.13
|